Promising diabetes delay study halted due to lack of participants

NCT ID NCT04291703

Terminated Disease control Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a low dose of a drug called ATG to see if it could delay or prevent type 1 diabetes in people at high risk. Only 2 people enrolled, so the study was stopped early. The goal was to measure how long it took for participants to develop full-blown diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

Barbara Davis Center at University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045, United States
Benaroya Research Institute

Seattle, Washington, 98101, United States
Children's Hospital of Iowa

Iowa City, Iowa, 52242, United States
Children's Hospital of Orange County

Orange, California, 92868, United States
Columbia University-Naomi Berrie Diabetes Center

New York, New York, 10032, United States
Emory Children's Center

Atlanta, Georgia, 30322, United States
Indiana University - Riley Hospital for Children

Indianapolis, Indiana, 46202, United States
Prisma Health

Greenville, South Carolina, 29615, United States
Queensland Children's Hospital

South Brisbane, Queensland, 4101, Australia
Stanford University

Stanford, California, 94305, United States
The Children's Mercy Hospital

Kansas City, Missouri, 64108, United States
University of California - San Francisco

San Francisco, California, 94143, United States
University of Florida

Gainesville, Florida, 32610, United States
University of Miami

Miami, Florida, 33136, United States
University of Minnesota

Minneapolis, Minnesota, 55455, United States
University of Pittsburgh

Pittsburgh, Pennsylvania, 15224, United States
University of South Florida Diabetes Center

Tampa, Florida, 33612, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States
University of Utah

Salt Lake City, Utah, 84132, United States
Vanderbilt Eskind Diabetes Center

Nashville, Tennessee, 37232, United States
Walter and Eliza Hall Institute of Medical Research

Melbourne, Victoria, 3050, Australia
Yale University School of Medicine

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.